|
|
Volumn 21, Issue 11, 2000, Pages 863-867
|
|
Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: What more needs to be proven?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
CORONARY STENT;
DRUG EFFICACY;
EDITORIAL;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
PRIORITY JOURNAL;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
CORONARY DISEASE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
RANDOMIZED CONTROLLED TRIALS;
STENTS;
|
|
EID: 0034068967
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.1999.1975 Document Type: Editorial |
|
Times cited : (5)
|
|
References (32)
|
